Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral uracil pharmacokinetics test in colorectal cancer patients
NL-OMON34808Phase 2Active, not recruiting
- Sponsor
- Scheper Ziekenhuis
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of uracil in colorectal cancer (CRC) and dihydropyrimidine dehydrogenase deficiency (2 arms), sponsored by Scheper Ziekenhuis. Primary endpoint: Area under the concentration-time curve of uracil. Started Aug 2011; status: active, not recruiting.
02
Drugs
uracil
03
Conditions
colorectal cancer (CRC)dihydropyrimidine dehydrogenase deficiency
Beyond the preview
Go deeper on NL-OMON34808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34808.